Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-01, Stock:LLY, The news for the past five days is as follows:
2018-10-25: NEWS1: Eli Lilly Is Just Taking a Normal Pause.NEWS2: Merck (MRK) Beats on Q3 Earnings, Lags Sales, Ups EPS View.NEWS3: Merck (MRK) Beats on Q3 Earnings, Lags Sales, Ups EPS View.NEWS4: How JNJ’s Invega Sustenna and Risperdal Consta Performed.NEWS5: Analysts See 10% Gains Ahead For DVOL.NEWS6: Analysts See 10% Gains Ahead For DVOL.NEWS7: Merck says to retain animal health business as part of company.NEWS8: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS9: Today's Research Reports on Trending Tickers: AstraZeneca and Eli Lilly and Company.
2018-10-26: NEWS1: How Is JNJ’s Cardiovascular & Metabolism Business Positioned?.NEWS2: See what the IHS Markit Score report has to say about Eli Lilly And Co..
2018-10-29: NEWS1: Biogen And Eisai May Be At Odds In Alzheimer's — So What Now?.NEWS2: Dicerna Soars After Eli Lilly Invests $100M In Licensing, Research Deal.NEWS3: Dicerna&apos;s stock rockets after licensing, research collaboration with Eli Lilly.NEWS4: Eli Lilly makes bet on gene-silencing drug firm Dicerna.NEWS5: Lilly and Dicerna Announce RNAi Licensing and Research Collaboration.NEWS6: Drug giant Lilly backs Cambridge&apos;s Dicerna in $200M deal.NEWS7: Dicerna Stock Surges On RNAi Deal With Lilly.NEWS8: Dicerna Stock Surges On RNAi Deal With Lilly.NEWS9: [$$] Follow the FDA’s Self-Interest.
2018-10-30: NEWS1: Incyte (INCY) Misses on Q3 Earnings & Revenues, Updates View.NEWS2: Incyte (INCY) Misses on Q3 Earnings & Revenues, Updates View.NEWS3: Pfizer Missed Analysts’ Third-Quarter Revenue Estimates.NEWS4: Incyte (INCY) Misses on Q3 Earnings & Revenues, Updates View.NEWS5: Allergan (AGN) Beats on Q3 Earnings, Raises 2018 Guidance.NEWS6: Allergan (AGN) Beats on Q3 Earnings, Raises 2018 Guidance.NEWS7: Sanofi: Analysts’ Recommendations on October 30.NEWS8: Sanofi’s Q3 Estimates: Expect Revenue Growth.NEWS9: Your first trade for Tuesday, Oct 30.NEWS10: Your first trade for Tuesday, Oct 30.NEWS11: This is Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS12: Better Buy: Celgene Corporation vs. Gilead Sciences.NEWS13: Better Buy: Celgene Corporation vs. Gilead Sciences.NEWS14: Elanco Animal Health Names Todd Young CFO - Quick Facts.NEWS15: Elanco Animal Health Names Todd Young CFO - Quick Facts.
2018-10-31: NEWS1: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS2: The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead.NEWS3: The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead.NEWS4: The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead.NEWS5: Sanofi's (SNY) Q3 Earnings and Sales Surpass Estimates.NEWS6: Sanofi's (SNY) Q3 Earnings and Sales Surpass Estimates.NEWS7: XLV, MDT, ABT, LLY: ETF Inflow Alert.NEWS8: XLV, MDT, ABT, LLY: ETF Inflow Alert.NEWS9: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS10: Dr. Reddy's Launches Atomoxetine Capsules, Generic Version Of Strattera, In U.S..NEWS11: Dr. Reddy's Launches Atomoxetine Capsules, Generic Version Of Strattera, In U.S..

Answer: Decrease